News
Thermo Fisher said on Wednesday the tariff situation was improving and raised the lower end of its annual profit forecast on ...
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Thermo Fisher Scientific Inc. (TMO) on Wednesday reported second-quarter profit of $1.62 billion. The Waltham, Massachusetts-based company said it had net ...
Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe Report finds Acceleratorâ„¢ cuts time oncology candidates spend in clinical trials by up to three years ...
5d
AZoM on MSNThe Future of Battery Diagnostics
The role of advanced imaging and cryogenic techniques in battery diagnostics is pivotal for understanding material behavior ...
4d
AZoM on MSNKey Considerations for Raman Analysis in Hazardous Zones
The following requirements and features must be considered when choosing Raman analyzers for hazardous environments: ...
Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical medicines for the French drugmaker.
Thermo Fisher Scientific Inc. research and ratings by Barron's. View TMO revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
According to the latest study from BCC Research, the "G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global ...
Review quarterly and annual revenue, net income, and cash flow for Thermo Fisher Scientific Inc (TMO:XNYS) stock through the last fiscal year.
See the latest Thermo Fisher Scientific Inc stock price (TMO:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
The GeneTitan family of instruments and proven GeneChip Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and ...
Complete Thermo Fisher Scientific Inc. stock information by Barron's. View real-time TMO stock price and news, along with industry-best analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results